evobrutinib,ozanimod,natalizumab,ocrelizumab,ata-188
merck,bms,amgen,roche,atara biotherapeutics,biogen
['advance', 'merck', 'bms']
ms drug advances from merck, bms and more showcased at ectrims conference | biospace #jobs
Disabled Veteran paying attention.